13 marzo 2024: Nuove prospettive per l’immunoterapia dei tumori polmonari emergono dai dati appena pubblicati, sulla prestigiosa rivista Nature Communications, dal gruppo di ricerca diretto dalla Dr. Federica Benvenuti presso l’ICGEB di Trieste.
Read More
March 13, 2024: New perspectives for lung cancer immunotherapy emerge from data just published, in the prestigious journal Nature Communications, by the research group led by Dr. Federica Benvenuti at the ICGEB in Trieste, Italy. The study was supported by AIRC Foundation for Cancer Research.
Read More
A major goal of ICGEB is to ensure that the fruits of modern molecular biology and biotechnology reach our populations and improve society and well-being in all of our Member countries.
Read More